nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching
|
Agid, Ofer |
|
2013 |
23 |
9 |
p. 1017-1022 6 p. |
artikel |
2 |
Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat
|
Shortall, Sinead E. |
|
2013 |
23 |
9 |
p. 1085-1095 11 p. |
artikel |
3 |
Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials
|
Dold, Markus |
|
2013 |
23 |
9 |
p. 1023-1033 11 p. |
artikel |
4 |
Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence
|
Corominas-Roso, Margarida |
|
2013 |
23 |
9 |
p. 1078-1084 7 p. |
artikel |
5 |
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor
|
Gomes, Felipe V. |
|
2013 |
23 |
9 |
p. 1096-1104 9 p. |
artikel |
6 |
Contents
|
|
|
2013 |
23 |
9 |
p. OBC- 1 p. |
artikel |
7 |
Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia? ☆ ☆☆ Previous publications and presentations: The primary results from this study are submitted elsewhere. Data in the manuscript were previously presented as a poster at the 66th Annual Convention and Scientific Program of the Society of Biological Psychiatry (SOBP), held in San Francisco, CA, USA from 12 to 14 May 2011; the 51st Annual Scientific Meeting New Clinical Drug Evaluation Unit (NCDEU), held in Boca Raton, FL, USA from 13 to 16 June 2011; and the 24th European College of Neuropsychopharmacology (ECNP) Congress, held in Paris, France, from 3 to 7 September 2011. ☆
|
Anghelescu, Ion-George |
|
2013 |
23 |
9 |
p. 1043-1050 8 p. |
artikel |
8 |
ECNP Calendar of Events
|
|
|
2013 |
23 |
9 |
p. I- 1 p. |
artikel |
9 |
Editorial Board
|
|
|
2013 |
23 |
9 |
p. IFC- 1 p. |
artikel |
10 |
Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial
|
Rubio-Valera, Maria |
|
2013 |
23 |
9 |
p. 1057-1066 10 p. |
artikel |
11 |
Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances
|
Schulze, Jana |
|
2013 |
23 |
9 |
p. 1034-1042 9 p. |
artikel |
12 |
Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro
|
Barzilay, Ran |
|
2013 |
23 |
9 |
p. 1115-1123 9 p. |
artikel |
13 |
Nanopsychiatry—The potential role of nanotechnologies in the future of psychiatry: A systematic review
|
Fond, G. |
|
2013 |
23 |
9 |
p. 1067-1071 5 p. |
artikel |
14 |
Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms
|
Levine, Stephen Z. |
|
2013 |
23 |
9 |
p. 1051-1056 6 p. |
artikel |
15 |
Schizophrenia and dopamine receptors
|
Seeman, Philip |
|
2013 |
23 |
9 |
p. 999-1009 11 p. |
artikel |
16 |
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia
|
Spineli, Loukia M. |
|
2013 |
23 |
9 |
p. 1010-1016 7 p. |
artikel |
17 |
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response
|
Powell, Timothy R. |
|
2013 |
23 |
9 |
p. 1105-1114 10 p. |
artikel |
18 |
Validation of an abbreviated quality of life scale for schizophrenia
|
Fervaha, Gagan |
|
2013 |
23 |
9 |
p. 1072-1077 6 p. |
artikel |